Journal of gynecologic oncology
Response to Corcept's retraction request on manuscript of "Relacorilant plus nab-paclitaxel for recurrent, platinum-resistant ovarian cancer: a cost-effectiveness study".
Qiaoping Xu
Published: 202510.3802/jgo.2025.36.e140
Abstract
Open AccessThis corrects the article on p. e139 in vol. 36.